Clearmind Medicine (CMND) Return on Equity [ROE] (2023 - 2026)
Clearmind Medicine (CMND) posted Return on Equity [ROE] of -80.12% for fiscal Q2 2026 (quarter ended Apr 30, 2026), up 107.43 percentage points from -187.55% a year earlier.
Powered by 
Analysis
Clearmind Medicine (CMND) Return on Equity [ROE] (2023 - 2026) Analysis & Trends
For FY2024 (ended Oct 31, 2024), Clearmind Medicine's Return on Equity [ROE] came in at -256.89%.
- Annual Return on Equity [ROE] shows a three-year change of -111.76 percentage points (FY2021 to FY2024).
- In prior fiscal years, Clearmind Medicine's Return on Equity [ROE] was -571.69% in FY2022 (-426.57 pp) and -145.12% in FY2021.
- The fiscal Q2 2026 figure stands as the highest quarterly Return on Equity [ROE] in data going back to fiscal Q1 2023.
- On a year-over-year basis, Return on Equity [ROE] increased in three of the last six quarters, with an average year-over-year change of +59.93 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was fiscal Q4 2024, with a gain of 269.37 percentage points; the weakest was fiscal Q2 2025, with a drop of 44.66 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Clearmind Medicine | 9,023.39 | 9,023.39 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -80.12% |
| Jul 31, 2025 | -240.79% |
| Apr 30, 2025 | -187.55% |
| Jan 31, 2025 | -166.36% |
| Oct 31, 2024 | -159.71% |
| Jul 31, 2024 | -207.91% |
| Apr 30, 2024 | -142.89% |
| Jan 31, 2024 | -250.54% |
| Oct 31, 2023 | -429.08% |
| Jul 31, 2023 | -184.06% |
| Apr 30, 2023 | -182.09% |
| Jan 31, 2023 | -487.35% |
API Access
Clearmind Medicine Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CMND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CMND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CMND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();